Sort
10,766 grants matching “checkpoint inhibitor”
Metabolites regulating macrophage function in colorectal cancer
$74,274Subbaya Subramanian · University Of Minnesota · R03 · FY2024 · CA
Using a Humanized Microbiome Mouse Model to Assess Therapeutic Response in Glioblastoma
$74,250Braden Cox McFarland · University Of Alabama At Birmingham · R03 · FY2020 · NS
Using a Humanized Microbiome Mouse Model to Assess Therapeutic Response in Glioblastoma
$74,250Braden Cox McFarland · University Of Alabama At Birmingham · R03 · FY2021 · NS
High Throughput/Content Screens for Dynein Inhibitors
$74,250Billy W Day · University Of Pittsburgh At Pittsburgh · R21 · FY2006 · NS
Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
$74,139Barbara Burtness · Yale University · P50 · FY2023 · DE
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
$74,139Barbara Burtness · Yale University · P50 · FY2023 · DE
OVERCOMING KIDNEY CANCER RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS
$74,030The University Of Texas Southwestern Medical Center · · FY2020 · Defense Health Agency
Impact of heme catabolism on triple negative breast cancer metastasis via immune-suppression
$73,958Michelle M Williams · University Of Colorado Denver · F32 · FY2021 · CA
Role of the Gut Microbiota in Regulating Responses to anti-PD-1 Cancer Immunotherapy
$73,942Joon Seok Park · Harvard Medical School · F32 · FY2022 · CA
Regulation of T cell activation and exhaustion by Tim-3
$73,932Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Program 30: Neuro-Oncology
$73,823Tracy T Batchelor · Dana-Farber Cancer Inst · P30 · FY2021 · CA
Epigenetic regulators of subtype plasticity in bladder cancer
$73,772John Robert Christin · Columbia University Health Sciences · F32 · FY2023 · CA
Mitotic Catastrophe in Tumor Cells
$73,749University Of Illinois At Chicago · R01 · FY2003 · CA
Program 30: Neuro-Oncology
$73,710Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2020 · CA
Y vh 1 p: phosphatase inhibitor of telomere signaling
$73,513University Of Kentucky · R03 · FY2003 · AG
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$73,448Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2023 · CA
Validation of new biomarker for human cancers
$73,238Francois X Claret · University Of Tx Md Anderson Can Ctr · R03 · FY2006 · CA
Covalent PD1 Antagonists: Discovery of Protein-Protein Interaction (PPI) Inhibitors in Cancer Immunotherapy
$73,221Stephane P Roche · Florida Atlantic University · R03 · FY2024 · CA
Identifying the role of Ntrk1 in immunosuppression in Kras/p53 mutant lung cancer
$73,158Jessica Konen · University Of Tx Md Anderson Can Ctr · F32 · FY2021 · CA
Program 4: Leukemia
$73,081Benjamin Levine Ebert · Dana-Farber Cancer Inst · P30 · FY2019 · CA
Engineering Nanomaterials to Prime Immunity
$73,079James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$72,891Lily Yang · Emory University · R01 · FY2025 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$72,857David B Shackelford · University Of California Los Angeles · R01 · FY2023 · CA
Mechanism of LSD1 Function and Its Therapeutic Application for Progressive Oral Malignancy
$72,474Manish Bais · Boston University Medical Campus · R01 · FY2024 · DE
Tumor Biology Program
$72,334Ann Marie Pendergast · Duke University · P30 · FY2020 · CA